FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4238576874> ?p ?o ?g. }

• W4238576874 endingPage "59C" @default.
• W4238576874 startingPage "54C" @default.
• W4238576874 abstract "The Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries trial (PLAC-II) was initiated in 1987 and was the first double-blind, randomized clinical trial with progression of early extracranial carotid atherosclerosis as an outcome variable. We randomized 151 coronary patients to placebo or pravastatin and treated them for 3 years. B-mode ultrasound quantification of carotid artery intimaimedial thickness (IMT) was obtained at baseline and sequentially during this period. The primary outcome was the change in the mean of the maximum IMT measurements over time. Effects on individual carotid artery segments (common, bifurcation, internal carotid artery) and on clinical events were also investigated. During follow-up, plasma concentrations of total cholesterol were lower in pravastatin-treated patients compared with those of placebo-treated patients (4.81 vs 6.08 mmol/ liter [186 vs 235 mg/dl]) as were concentrations of low density lipoprotein (LDL) cholesterol (3.10 vs 4.29 mmol/liter [120 vs 167 mg/dl]). Plasma concentrations of high density Iipoprotein2 (HOL2) cholesterol were higher in pravastatin-treated patients than in placebo-treated patients (0.16 vs 0.14 mmol/liter [6.1 vs 5.5 mg/dl]). Active treatment resulted in a nonsignificant 12% reduction in progression of the mean-maximum IMT (from 0.068 mm/yr placebo to 0.059 mm/yr pravastatin) and a statistically significant 35% reduction in IMT progression in the common carotid (p = 0.03). Active treatment was also associated with a 60% reduction of nonfatal myocardial infarction plus death caused by coronary artery disease (p = 0.09), a 61% reduction of any fatal event plus any nonfatal myocardial infarction (p = 0.04), and an 80% reduction of fatal plus any nonfatal myocardial infarction (p = 0.03). The Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries trial (PLAC-II) was initiated in 1987 and was the first double-blind, randomized clinical trial with progression of early extracranial carotid atherosclerosis as an outcome variable. We randomized 151 coronary patients to placebo or pravastatin and treated them for 3 years. B-mode ultrasound quantification of carotid artery intimaimedial thickness (IMT) was obtained at baseline and sequentially during this period. The primary outcome was the change in the mean of the maximum IMT measurements over time. Effects on individual carotid artery segments (common, bifurcation, internal carotid artery) and on clinical events were also investigated. During follow-up, plasma concentrations of total cholesterol were lower in pravastatin-treated patients compared with those of placebo-treated patients (4.81 vs 6.08 mmol/ liter [186 vs 235 mg/dl]) as were concentrations of low density lipoprotein (LDL) cholesterol (3.10 vs 4.29 mmol/liter [120 vs 167 mg/dl]). Plasma concentrations of high density Iipoprotein2 (HOL2) cholesterol were higher in pravastatin-treated patients than in placebo-treated patients (0.16 vs 0.14 mmol/liter [6.1 vs 5.5 mg/dl]). Active treatment resulted in a nonsignificant 12% reduction in progression of the mean-maximum IMT (from 0.068 mm/yr placebo to 0.059 mm/yr pravastatin) and a statistically significant 35% reduction in IMT progression in the common carotid (p = 0.03). Active treatment was also associated with a 60% reduction of nonfatal myocardial infarction plus death caused by coronary artery disease (p = 0.09), a 61% reduction of any fatal event plus any nonfatal myocardial infarction (p = 0.04), and an 80% reduction of fatal plus any nonfatal myocardial infarction (p = 0.03)." @default.
• W4238576874 created "2022-05-12" @default.
• W4238576874 creator A5053080802 @default.
• W4238576874 creator A5053278328 @default.
• W4238576874 creator A5063990946 @default.
• W4238576874 creator A5067091931 @default.
• W4238576874 creator A5067354051 @default.
• W4238576874 date "1995-09-01" @default.
• W4238576874 modified "2023-10-18" @default.
• W4238576874 title "Pravastatin, lipids, and atherosclerosis in the carotid arteries (plac-II)" @default.
• W4238576874 cites W1964568991 @default.
• W4238576874 cites W1965408926 @default.
• W4238576874 cites W1972165634 @default.
• W4238576874 cites W2007963531 @default.
• W4238576874 cites W2009568940 @default.
• W4238576874 cites W2017499355 @default.
• W4238576874 cites W2023328539 @default.
• W4238576874 cites W2025321056 @default.
• W4238576874 cites W2038688357 @default.
• W4238576874 cites W2051846979 @default.
• W4238576874 cites W2054097500 @default.
• W4238576874 cites W2064279221 @default.
• W4238576874 cites W2066711466 @default.
• W4238576874 cites W2082246284 @default.
• W4238576874 cites W2088224677 @default.
• W4238576874 cites W2131343690 @default.
• W4238576874 cites W2160163186 @default.
• W4238576874 cites W2166761125 @default.
• W4238576874 cites W2189623052 @default.
• W4238576874 doi "https://doi.org/10.1016/s0002-9149(99)80471-8" @default.
• W4238576874 hasPublicationYear "1995" @default.
• W4238576874 type Work @default.
• W4238576874 citedByCount "80" @default.
• W4238576874 countsByYear W42385768742012 @default.
• W4238576874 countsByYear W42385768742013 @default.
• W4238576874 countsByYear W42385768742014 @default.
• W4238576874 countsByYear W42385768742015 @default.
• W4238576874 countsByYear W42385768742016 @default.
• W4238576874 countsByYear W42385768742017 @default.
• W4238576874 countsByYear W42385768742020 @default.
• W4238576874 countsByYear W42385768742021 @default.
• W4238576874 countsByYear W42385768742023 @default.
• W4238576874 crossrefType "journal-article" @default.
• W4238576874 hasAuthorship W4238576874A5053080802 @default.
• W4238576874 hasAuthorship W4238576874A5053278328 @default.
• W4238576874 hasAuthorship W4238576874A5063990946 @default.
• W4238576874 hasAuthorship W4238576874A5067091931 @default.
• W4238576874 hasAuthorship W4238576874A5067354051 @default.
• W4238576874 hasConcept C126322002 @default.
• W4238576874 hasConcept C142724271 @default.
• W4238576874 hasConcept C164705383 @default.
• W4238576874 hasConcept C176674119 @default.
• W4238576874 hasConcept C204787440 @default.
• W4238576874 hasConcept C27081682 @default.
• W4238576874 hasConcept C2778163477 @default.
• W4238576874 hasConcept C2778213512 @default.
• W4238576874 hasConcept C2779519902 @default.
• W4238576874 hasConcept C500558357 @default.
• W4238576874 hasConcept C71924100 @default.
• W4238576874 hasConceptScore W4238576874C126322002 @default.
• W4238576874 hasConceptScore W4238576874C142724271 @default.
• W4238576874 hasConceptScore W4238576874C164705383 @default.
• W4238576874 hasConceptScore W4238576874C176674119 @default.
• W4238576874 hasConceptScore W4238576874C204787440 @default.
• W4238576874 hasConceptScore W4238576874C27081682 @default.
• W4238576874 hasConceptScore W4238576874C2778163477 @default.
• W4238576874 hasConceptScore W4238576874C2778213512 @default.
• W4238576874 hasConceptScore W4238576874C2779519902 @default.
• W4238576874 hasConceptScore W4238576874C500558357 @default.
• W4238576874 hasConceptScore W4238576874C71924100 @default.
• W4238576874 hasIssue "9" @default.
• W4238576874 hasLocation W42385768741 @default.
• W4238576874 hasOpenAccess W4238576874 @default.
• W4238576874 hasPrimaryLocation W42385768741 @default.
• W4238576874 hasRelatedWork W2002227424 @default.
• W4238576874 hasRelatedWork W2008851126 @default.
• W4238576874 hasRelatedWork W2049397185 @default.
• W4238576874 hasRelatedWork W2083775127 @default.
• W4238576874 hasRelatedWork W2085050035 @default.
• W4238576874 hasRelatedWork W2088935147 @default.
• W4238576874 hasRelatedWork W2399063111 @default.
• W4238576874 hasRelatedWork W2417414779 @default.
• W4238576874 hasRelatedWork W2473563255 @default.
• W4238576874 hasRelatedWork W2790353319 @default.
• W4238576874 hasVolume "76" @default.
• W4238576874 isParatext "false" @default.
• W4238576874 isRetracted "false" @default.
• W4238576874 workType "article" @default.